Peer Review reports
From: Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei
| Original Submission | ||
|---|---|---|
| 15 Jul 2022 | Submitted | Original manuscript |
| 8 Aug 2022 | Reviewed | Reviewer Report |
| 1 Sep 2022 | Reviewed | Reviewer Report |
| 10 Sep 2022 | Author responded | Author comments - Christine Clayton |
| Resubmission - Version 2 | ||
| 10 Sep 2022 | Submitted | Manuscript version 2 |
| 3 Oct 2022 | Reviewed | Reviewer Report |
| 15 Oct 2022 | Reviewed | Reviewer Report |
| 18 Oct 2022 | Author responded | Author comments - Christine Clayton |
| Resubmission - Version 3 | ||
| 18 Oct 2022 | Submitted | Manuscript version 3 |
| 14 Nov 2022 | Reviewed | Reviewer Report |
| 22 Nov 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 30 Nov 2022 | Editorially accepted | |
| 17 Dec 2022 | Article published | 10.1186/s13104-022-06258-y |
You can find further information about peer review here.